Rio-Vilariño, A., Cenigaonandia-Campillo, A., García-Bautista, A., Mateos-Gómez, P. A., Schlaepfer, M. I., del Puerto-Nevado, L., Aguilera, O., García-García, L., Galeano, C., de Miguel, I., Serrano-López, J., Baños, N., Fernández-Aceñero, M. J., Lacal, J. C., Medico, E., García-Foncillas, J., & Cebrián, A. (2024). Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British Journal of Cancer, 130(8), 1402-1413. https://doi.org/10.1038/S41416-024-02649-Z